Clinical Assistant Professor, Department of Medicine
Biosketch
Andrew C. Heisler, MD, MSCI is a board-certified rheumatologist with Bronson Rheumatology Specialists in Kalamazoo, Michigan. He earned his undergraduate and medical degrees from Loyola University Chicago. Following medical school, he completed an internal medicine residency at Loyola University Health Center in Maywood, IL. He completed his subspecialty training in rheumatology at Northwestern University McGaw Medical Center in Chicago, IL, where he additionally completed a Master of Science in Clinical Investigation. Following his clinical fellowship, he completed a NIH T32 fellowship at Northwestern to gain further clinical research skills.
Dr. Heisler's research interests include understanding mechanisms of chronic pain in inflammatory arthritis. Dr. Heisler also has an interest in the use of patient reported outcomes to better understand the patient experience in inflammatory arthritis. Dr. Heisler's clinical interests include rheumatoid arthritis, psoriatic arthritis, crystal arthritis, and vasculitis.
-
Education and Training
- MSCI 2020, Clinical Investigation, Feinberg School of Medicine, Northwestern University
- Postdoctoral Research Fellowship 2020, NIH T32 Rheumatology Research Fellowship, Northwestern University
- Fellowship 2019, Rheumatology, Northwestern University
- Residency 2017, Internal Medicine, Loyola University Medical Center - Maywood
- MD 2014, Stritch School of Medicine, Loyola University-Chicago
- BS 2009, Biology, Loyola University-Chicago
-
Research
- Spondylarthritis
- Rheumatoid Arthritis
- Research Methods/Statistics
- Patent research
- Pain Measurement
- Clinical rheumatolgy
- Clinical Research or Studies
- Arthritis treatments
-
Publications
Gorzewski A.M., Heisler A.C., Neogi T., Muhammad L.N., Song J., Dunlop D., Bingham C.O., Bolster M.B., Clauw D.J., Marder W., Lee Y.C. Predicting Disease Activity in Rheumatoid Arthritis With the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter? The Journal of rheumatology. 2023;50:684-689.
Qiu Y.Y., Neogi T., Muhammad L.N., Song J., Bolster M.B., Marder W., Heisler A.C., Wohlfahrt A., Dunlop D., Lee Y.C. Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis Annals of the Rheumatic Diseases. 2023;82:1638-1640.
Janus S.E., Heisler A.C., Al Jamal M., Chahine N., Chami T., Hajjari J., Mously H., Badhwar A., Arora S., Al-Juhaishi T., Al-Kindi S.G., Hoit B.D. Reported Pericardial Toxicities Associated with Acute Myelogenous Leukemia Treatments: A Pharmacovigilance Analysis of the FDA Adverse Reporting Database Current Problems in Cardiology. 2022;47
Moore M.N., Wallace B.I., Song J., Muhammad L.N., Heisler A.C., Clauw D.J., Bolster M.B., Marder W., Neogi T., Wohlfahrt A., Dunlop D.D., Lee Y.C. Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis Journal of Rheumatology. 2022;49:1052-1057.
Shah N.N., Wass S., Hajjari J., Heisler A.C., Malakooti S., Janus S.E., Al-Kindi S.G. Proportionate Cardiovascular Mortality in Chronic Inflammatory Disease in Adults in the United States from 1999 to 2019 Journal of Clinical Rheumatology. 2022;28:97-103.
Wallace B.I., Moore M.N., Heisler A.C., Muhammad L.N., Song J., Clauw D.J., Bingham C.O., Bolster M.B., Marder W., Neogi T., Wohlfahrt A., Dunlop D.D., Lee Y.C. Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis Rheumatology (United Kingdom). 2022;61:1556-1562.
Heisler A.C., Song J., Dunlop D.D., Wohlfahrt A., Bingham C.O., Bolster M.B., Clauw D.J., Marder W., Phillips K., Neogi T., Lee Y.C. Association of Pain Centralization and Patient-Reported Pain in Active Rheumatoid Arthritis Arthritis Care and Research. 2020;72(8):1122-1129.
Heisler A.C., Song J., Muhammad L.N., Wohlfahrt A., Marder W., Bolster M.B., Bingham C.O., Clauw D.J., Dunlop D.D., Neogi T., Lee Y.C. Association of Dysregulated Central Pain Processing and Response to Disease–Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis Arthritis and Rheumatology. 2020;72:2017-2024.